Midven News

Future Planet Capital (FPC) has announced its acquisition of one of Britain’s most respected venture capital firms, Midven Ltd. The deal will enable Future Planet to grow its extensive global innovation network, which includes Berkeley, Cambridge, Harvard, MIT and Oxford, by combining them with Midven’s access to top-ranked UK Government funded scientific research. FPC is already a […]

read more

Since 1993, the Birmingham-based venture capital firm has played a leading role in fuelling the region’s growth and innovation. Birmingham – 4 October 2018 — Leading venture capital firm Midven is celebrating a landmark 25 years of investment in the West Midlands. Midven has invested more than £60m into the region and raised £200m co-investment […]

read more

Acquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy program for glaucoma TOKYO, CAMBRIDGE (UK), August 10, 2018 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa,Ph.D., “Astellas”) and Quethera Limited (CEO: Peter Widdowson, Ph.D., “Quethera”) today announced that Astellas has acquired Quethera, a gene therapy company headquartered […]

read more

1 2 3 13
Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now

×